SCHEMBL6002181

SCHEMBL6002181

C=CCC(CN(C)C(=O)c1cc(C#N)cc2c1CCCC2)c1ccc(F)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 2/20 0.36
XDH P47989 1/20 0.33
SLC22A12 Q96S37 1/20 0.33
CXCR5 P32302 1/20 0.32
MCHR1 Q99705 1/20 0.32
LMNA P02545 1/20 0.31
MAPK1 P28482 1/20 0.31
SLC6A4 P31645 1/20 0.31
TACR2 P21452 1/20 0.31
TACR1 P25103 1/20 0.31
TACR3 P29371 1/20 0.31
NLRP3 Q96P20 1/20 0.31
SLC1A2 P43004 1/20 0.31
KCNH2 Q12809 1/20 0.31
EPHX2 P34913 1/20 0.31
MEN1 O00255 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
PDPK1 O15530 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4261305 1.00 NSD2 (0.36) NSD2XDHSLC22A12CXCR5MCHR1
SCHEMBL4262594 0.98 XDH (0.35) NSD2XDHSLC22A12CXCR5MCHR1
SCHEMBL6002296 0.92 NSD2 (0.36) NSD2XDHSLC22A12CXCR5MCHR1
SCHEMBL3229984 0.92 NSD2 (0.36) NSD2XDHSLC22A12CXCR5MCHR1
SCHEMBL4262995 0.90 XDH (0.35) NSD2XDHSLC22A12MCHR1LMNA
SCHEMBL4261808 0.90 XDH (0.32) NSD2XDHSLC22A12CXCR5NLRP3
SCHEMBL4261683 0.89 MEN1 (0.33) CXCR5MEN1HTTKMT2A
SCHEMBL6002556 0.87 TACR2 (0.33) TACR2TACR1TACR3
SCHEMBL6002190 0.81 XDH (0.32) NSD2XDHSLC22A12CXCR5NLRP3
SCHEMBL4260457 0.81 XDH (0.32) NSD2XDHSLC22A12CXCR5NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1636221-A2 NEW AZETIDINE COMPOUNDS AstraZeneca AB (SE) 2006-03-22 EP disclosed
WO-2004110344-A2 NEW AZETIDINE COMPOUNDS ASTRAZENECA AB (SE) 2004-12-23 WO disclosed